Treatment effects of Xuebijing injection in severe septic patients with disseminated intravascular coagulation

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Yin, Qin ^a   Li, Chunsheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HERBACEOUS AGENT; UNCLASSIFIED DRUG; XBJ INJECTION; XUEBIJING INJECTION;

ADULT; AGED; APACHE; ARTICLE; CHINESE MEDICINE; COMPARATIVE STUDY; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTHROMBIN TIME; SEPSIS; SIDE EFFECT; THROMBOCYTE COUNT;

EID: 84899541139     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/949254     Document Type: Article

References (31)

1. Angus D. C., Linde-Zwirble W. T., Lidicker J., Clermont G., Carcillo J., Pinsky M. R., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Critical Care Medicine 2001 29 7 1303 1310 2-s2.0-0034958947
2. Levi M., ten Cate H., Disseminated intravascular coagulation. The New England Journal of Medicine 1999 341 8 586 592 2-s2.0-0033584457 10.1056/NEJM199908193410807
3. Zeerleder S., Hack C. E., Wuillemin W. A., Disseminated intravascular coagulation in sepsis. Chest 2005 128 4 2864 2875 2-s2.0-27144451165 10.1378/chest.128.4.2864
4. Bick R. L., Disseminated intravascular coagulation current concepts of etiology, pathophysiology, diagnosis, and treatment. Hematology/Oncology Clinics of North America 2003 17 1 149 176 2-s2.0-0037319114 10.1016/S0889-8588(02) 00102-8
5. Sakuragawa N., Hasegawa H., Maki M., Nakagawa M., Nakashima M., Clinical evaluation of low-molecular-weight heparin (FR-860) on disseminated intravascular coagulation (DIC)-a multicenter co-operative double-blind trial in comparison with heparin. Thrombosis Research 1993 72 6 475 500 2-s2.0-0027383665 10.1016/0049-3848(93)90109-2
6. Aoki N., Matsuda T., Saito H., Takatsuki K., Okajima K., Takahashi H., Takamatsu J., Asakura H., Ogawa N., A comparative double-blind randomized trial of activated protein C and unfractionated heparin in the treatment of disseminated intravascular coagulation. International Journal of Hematology 2002 75 5 540 547 2-s2.0-0012461468
7. Bernard G. R., Vincent J.-L., Laterre P.-F., LaRosa S. P., Dhainaut J.-F., Lopez-Rodriguez A., Steingrub J. S., Garber G. E., Helterbrand J. D., Ely E. W., Fisher C. J., Efficacy and safety of recombinant human activated protein C for severe sepsis. The New England Journal of Medicine 2001 344 10 699 709 2-s2.0-0035826096 10.1056/NEJM200103083441001
8. Dhainaut J.-F., Yan S. B., Joyce D. E., Pettilä V., Basson B., Brandt J. T., Sundin D. P., Levi M., Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis 2004 2 11 1924 1933 2-s2.0-1842547895 10.1111/j.1538-7836.2004.00955.x
9. Ranieri V. M., Thompson B. T., Barie P. S., Drotrecogin alfa (activated) in adults with septic shock. The New England Journal of Medicine 2012 366 22 2055 2064 10.1056/NEJMoa1202290
10. Dellinger R. P., Levy M. M., Rhodes A., Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Critical Care Medicine 2013 41 2 580 637
11. Jia P., Wang S., Meng X., Effects of ionic liquid and nanogold particles on high-performance liquid chromatography-electrochemical detection and their application in highly efficient separation and sensitive analysis of five phenolic acids in Xuebijing injection. Talanta 2013 107 103 110 10.1016/j.talanta.2012.12.031
12. Li N., Jiang L. W., Yu L., Systematic review of Xuebijing injection for the treatment of sepsis. Chinese Journal of Modern Drug Application 2013 7 22 8 11
13. Guo N., Liu Q. Q., Miao Q., Jiang Q.-M., Effects of Xuebijing injection in 4 patients with disseminated intravascular coagulation. Chinese Critical Care Medicine 2007 19 7 441
14. Chen Z. Y., Effects of Xuebijing injection in 30 patients with disseminated intravascular coagulation. Shanxi Medical Journal 2008 37 6 732 733
15. Levy M. M., Fink M. P., Marshall J. C., Abraham E., Angus D., Cook D., Cohen J., Opal S. M., Vincent J.-L., Ramsay G., 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Critical Care Medicine 2003 31 4 1250 1256 2-s2.0-0037389094 10.1097/01.CCM.0000050454.01978.3B
16. Taylor F. B. Jr., Toh C.-H., Hoots W. K., Wada H., Levi M., Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation: on behalf of the scientific subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haematostasis (ISTH). Thrombosis and Haemostasis 2001 86 5 1327 1330 2-s2.0-0035160476
17. Shapiro N. I., Wolfe R. E., Moore R. B., Smith E., Burdick E., Bates D. W., Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Critical Care Medicine 2003 31 3 670 675 2-s2.0-0037351815 10.1097/01.CCM.0000054867.01688.D1
18. Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E., APACHE II: a severity of disease classification system. Critical Care Medicine 1985 13 10 818 829 2-s2.0-0022256529
19. Luo G. A., Wang Y. M., Classification and development of traditional Chinese medicine fingerprint. Chinese Journal of New Drugs 2002 11 1 46 51
20. Huang H., Ji L., Song S., Wang J., Wei N., Jiang M., Bai G., Luo G., Identification of the major constituents in Xuebijing injection by HPLC-ESI-MS. Phytochemical Analysis 2011 22 4 330 338 2-s2.0-79959287943 10.1002/pca.1284
21. Jiang M., Zhou M., Han Y., Identification of NF- B Inhibitors in Xuebijing injection for sepsis treatment based on bioactivity-integrated UPLC-Q/TOF. Journal of Ethnopharmacology 2013 147 2 426 433 10.1016/j.jep.2013. 03.032
22. Dai J. J., Cao S. H., Wang J. D., The protective effect of Xuebijing on the vascular endothelium of critical patients. Chinese General Practice 2005 8 18 1486 1487
23. Chen M., Fei A. H., Lu W. W., Clinical research on the therapeutic effect of Xuebijing injection on sepsis and its influence on PECAM-1 and coagulation function. Modern Journal of Integrated Traditional Chinese and Western Medicine 2012 21 11 1156 1158
24. Tang L. Q., Peng N., Pan Z. G., Tong H., Su L., The effect of Xuebijing injection on the coagulation parameters and outcome of the patients with severe sepsis. Chinese Journal of Integrated Traditional Chinese and Western Medicine in Critical Care 2012 19 3 132 136
25. Zhang L. D., Pei X. J., Effects of Xuebijing parenteral solution on blood coagulation function and blood gas analysis in severe sepsis patients. Chinese Journal of Critical Care Medicine 2012 32 12 1088 1091
26. Qi F., Liang Z.-X., She D.-Y., Yan G.-T., Chen L.-A., A clinical study on the effects and mechanism of Xuebijing injection in severe pneumonia patients. Journal of Traditional Chinese Medicine 2011 31 1 46 49 2-s2.0-79956104011
27. Song Y. L., Song Z. J., Jiang J. J., Clinical efficacy and safety evaluation of Xuebijing on severe pneumonia. International Journal of Respiration 2012 32 22 1692 1695
28. Gando S., Saitoh D., Ogura H., Mayumi T., Koseki K., Ikeda T., Ishikura H., Iba T., Ueyama M., Eguchi Y., Ohtomo Y., Okamoto K., Kushimoto S., Endo S., Shimazaki S., Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Critical Care Medicine 2008 36 1 145 150 2-s2.0-37548998584 10.1097/01.CCM.0000295317.97245.2D
29. Okabayashi K., Wada H., Ohta S., Shiku H., Nobori T., Maruyama K., Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit. American Journal of Hematology 2004 76 3 225 229 2-s2.0-3042602313 10.1002/ajh.20089
30. Cauchle P., Cauchie C., Boudjeltia K. Z., Carlier E., Deschepper N., Govaerts D., Migaud-Fressart M., Woodhams B., Brohée D., Diagnostic and prognosis of overt disseminated intravascular coagulation in a general hospital-meaning of the isth score system, fibrin monomers, and lipoprotein-C-reactive protein complex formation. American Journal of Hematology 2006 81 6 414 419 2-s2.0-33646875104 10.1002/ajh.20597
31. Kienast J., Juers M., Wiedermann C. J., Hoffmann J. N., Ostermann H., Strauss R., Keinecke H.-O., Warren B. L., Opal S. M., Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation. Journal of Thrombosis and Haemostasis 2006 4 1 90 97 2-s2.0-33644859949 10.1111/j.1538-7836.2005.01697.x